Clinical trial
Islet Transplantation Using Abatacept
NCT00276250 · Emory University, Other · Completed
Key facts
| NCT number | NCT00276250 |
|---|---|
| Title | Islet Transplantation Using Abatacept |
| Official title | Development of Immunosuppression Regimens to Facilitate Single Donor Islet Transplantation Using Abatacept |
| Lead sponsor | Emory University, Other |
| Collaborators | Juvenile Diabetes Research Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Efalizumab, Abatacept, Belatacept |
| Enrollment | 5 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Jan 13, 2006 |
| Last update posted | Jul 27, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: